dwinnex.com

Incyte Corporation [NASDAQ:INCY]: Analyst Rating and Earnings

Stock market traders oftentimes pay a lot of attention to what top analysts say regarding a potential investment. Regarding Incyte Corporation [INCY], the latest average analyst recommendation we can see is from the quarter closing in December. On average, stock market experts give INCY an Outperform rating. Its stock price has been found in the range of 57.00 to 88.83. This is compared to its latest closing price of $75.99.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Incyte Corporation [INCY] is sitting at 2.25. This is compared to 1 month ago, when its average rating was 2.14.

For the quarter ending in Mar-19 Incyte Corporation [INCY] generated $0.5 billion in sales. That’s 2.41% higher than the average estimate of $0.49 billion as provided by Wall Street analysts. The three indicators above suggest that overall, this stock is demonstrating a mixed bag of positive appeal and some drawbacks, making it a somewhat risky investment that also has the potential to generate high ROI in the long run.

Pay attention for this company’s financial results, of which the next release is scheduled to happen on Tue 30 Jul (In 75 Days).

Fundamental Analysis of Incyte Corporation [INCY]

Now let’s turn to look at profitability: with a current Operating Margin for Incyte Corporation [INCY] sitting at +8.26 and its Gross Margin at +93.22, this company’s Net Margin is now 12.70%. These measurements indicate that Incyte Corporation [INCY] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

This company’s Return on Total Capital is 8.64, and its Return on Invested Capital has reached 6.30%. Its Return on Equity is 6.16, and its Return on Assets is 4.43. These metrics show a mixed bag, which means that this investment’s attractiveness can be quickly increased or decreased in the short term, depending on future updates INCY financial performance.

Turning to investigate this organization’s capital structure, Incyte Corporation [INCY] has generated a Total Debt to Total Equity ratio of 0.91. Similarly, its Total Debt to Total Capital is 0.90, while its Total Debt to Total Assets stands at 0.66. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 0.91, and its Long-Term Debt to Total Capital is 0.90. This company has a healthy balance between its debt and its current holdings, suggesting it is a reliable investment due to its ability to leverage debt in an efficient way.

What about valuation? This company’s Enterprise Value to EBITDA is 75.49 and its Total Debt to EBITDA Value is 0.08. The Enterprise Value to Sales for this firm is now 7.95, and its Total Debt to Enterprise Value stands at 0.00. Incyte Corporation [INCY] has a Price to Book Ratio of 7.04, a Price to Cash Flow Ratio of 40.78 and P/E Ratio of 66.58. These metrics suggest that this publicly-traded organization will not likely result in investment gains.

Shifting the focus to workforce efficiency, Incyte Corporation [INCY] earns $1,376,652 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.56 and its Total Asset Turnover is 0.76. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 4.29 and its Current Ratio is 4.31. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Incyte Corporation [INCY] has 218.00M shares outstanding, amounting to a total market cap of $16.57B. Its stock price has been found in the range of 57.00 to 88.83. At its current price, it has moved by -12.21% from its 52-week high, and it has moved 36.81% from its 52-week low.

This stock’s Beta value is currently 1.25, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 45.93. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Incyte Corporation [INCY] a Reliable Buy?

Shares of Incyte Corporation [INCY], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.